"This is potentially the holy grail of cancer research, to find cancers that are now hard to cure at an earlier stage when they are easier to cure, and we hope this test could save many lives", lead author Eric Klein, an oncologist at the Cleveland Clinic in OH, tells The Telegraph.
"This is potentially the holy grail of cancer research, to find cancers that are now hard to cure at an earlier stage when they are easier to cure", said lead study author Dr Eric Klein, from the Cleveland Clinic's Taussig Cancer Institute, in Ohio.
"We need to work out why these blood tests failed to spot lung cancer in around half of cancer patients with early stage disease, whether it's effective in people without symptoms, and ultimately whether it can save lives".
Scientists from the Stanford University, who also contributed to the study, attended the annual conference of the American Society of Clinical Oncologists in Chicago. While it detected ovarian cancer with 90 percent success rate, for example, only 10 instances of this type of cancer were detected throughout the testing period.
Three sequencing techniques, analysing cell-free DNA in the blood, were between 38% and 51% accurate at detecting early-stage lung cancers, the research found.
He said: As the NHS marks its 70th anniversary, we stand on the cusp of a new era of personalised medicine that will dramatically transform care for cancer and for inherited and rare diseases.
Rudy Giuliani: Trump ‘probably’ has the power to pardon himself
His lead attorney, Rudy Giuliani , says the commander in chief " probably does" have the legal ability to take such an action. Giuliani also confirmed that Trump still wants to testify to Mueller, but his legal team has advised him not to do so.
It was 77 per cent accurate in diagnosing lymphoma, 73 per cent accurate for myeloma, and 80 per cent accurate for liver and gallbladder cancers.
"In stage I disease, surgical interventions are most likely to remove all a patient's cancer and result in a cure - this data is no yet available", Abbosh said.
The research examined the cases of more than 1600 people.
We all have to sit for a blood test once in our lifetime.
"While there's still a way to go before cell-free DNA from blood can be used for cancer detection on a broad scale, this research serves as a building block for the development of future tests". Finally, it will be important to establish how good this test is at identifying patients with the earliest stage of cancer.
Dr. H. Gilbert Welch, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice, said in a previous CNN report that the analysis involved in these tests is "extraordinarily complex".